Perspectivas para el control del Virus de la Diarrea Viral Bovina (BVDV)


  • Diana S. Vargas
  • Jairo Jaime
  • Víctor J. Vera



control programs, conventional vaccines, experimental vaccines



Bovine Viral Diarrhea Virus (BVDV) is one of the most important infectious agents in cattle population. BVDV is widespread throughout the world and it is endemic disease in most of the cattle population where 40 to 80% are seropositive. It causes economic losses mainly in breeding cattle. BVDV genetic and antigenic diversity is due to the virus high mutation and recombination frequency, which is reflected in many clinical manifestations and the difficult control of the disease. Control and prevention measures implemented by some countries are based on the elimination of the main source of infection: the persistently infected animals (PI animals), as well as the improvement of the immune response through the use of vaccines. Immunization with inactivated and modified-live vaccines has been used for decades without any significant improvement. New experimental strategies are being developed: recombinant vaccines where BVDV specific genes are selected in order to immunize cattle and thus overcome the shortcomings of conventional vaccines.



= 59 veces | PDF
= 20 veces|


Download data is not yet available.


Agapov E, Murray C, Frolov I, Qu L, Myers T. Uncleaved NS2-3 is required for production of infectious bovine viral diarrhea viral. J virol 2004; 78: 2414-2425.

Baker JC. Bovine viral diarrhea virus: a review. J Am Vet Med Assoc 1987; 190: 1449-58.

Birk A, Dubovi E, Cohen-Gould L, Donis R, Szeto H. Cytoplasmic vacuolization responses to cytopathic bovine viral diarrhea virus. Virus Research 2008; 132: 76-85.

Bolin S, Grooms D. Origination and consequences of bovine viral diarrhea virus diversity. Vet Clin Food Anim 2004; 20: 51-86.

Borda A. Diarrea viral bovina en terneros y terneras procedentes de Holanda. Tesis de pregrado, Facultad de Medicina Veterinaria, Universidad Nacional de Colombia, Bogotá, 1975.Bostock CJ. Virus as vectors. Vet microbiology 1990; 23: 55-62.

Brodersen B. Immunohistochemistry used as a screening method for persistent bovine viral diarrhea virus infection. Vet Clin Food Anim 2004; 20: 85-93.

Campbell J. Effect of bovine viral diarrhea virus in the feedlot. Vet Clin Food Anim 2004; 20: 39-50.

Castañeda V. Implementación de la técnica de inmunohistoquími-ca para la detección del VDVB utilizando Acs monoclonales 15c5 en tejidos fi jados con formol. Tesis de pregrado, Facultad de Medicina Veterinaria y de Zootecnia, Universidad Nacional de Colombia, Bogotá ,2004.

Chul B, Walz P, Kennedy G, Kapil S. Biotype, genotype and clinical presentation associated with bovine viral diarrhea virus isolates from cattle. Intern J Appl Res Vet Med 2005; 3: 319-25.

Donofrio G, Bottarrelli E, Sandro C, Filippo C. Expression of Bovine Viral Diarrhea Virus Glycoprotein E2 as a soluble form in a Mammalian cell line. Clinical and vaccine immunology 2006; 13: 698-701.

Elahi SM, Shen SH, Harpin S, Talbot BG, Elazhary Y. Investigation of the inmunological properties of the bovine viral diarrea virus protein NS3 expressed by an adenovirus vector in mice. Arch Virol 1999; 144:1057-1070.

Elahi SM, Shen SH, Talbot BG, Massie B, Harpin S, Elazhary Y. Induction of humoral and cellular immune responses against the nucleocapsid of bovine viral diarrhea virus by adenovirus vector with an inducible promoter. Virology 1999; 261: 1-7.

Flores E, Ridpath J, Weiblen R, Vogel F, Gil L. Phylogenetic analysis of Brazilian Bovine Viral Diarrhea Virus type 2 (BVDV-2) isolates: Evidence for a a subgenotype within BVDV-2. Virus Research 2002; 87: 51-60.

Fourichon C, Beaudeau F, Bareille N, Seegers H. Quantifi cation of economic losses consecutive to infection of a dairy herd with Bovine Viral Diarrhea Virus. Prev Vet Med 2005; 72: 177-81.

Grooms D. Reproductive consequences of infection with bovine viral diarrhea virus. Vet Clin North Am 2004; 20:5-19.

Gunn G, Saatkamp H, Humphry R, Stot A. 2005. Assesing economic and social pressure for the control of BVDV. Prev Vet Med 2005; 72: 149-162.

Harpin S, Hurley D, Mbikay M, Talbot B, Elazhary Y. Vaccination of cattle with a DNA plasmid encoding the Bovine Viral Diarrhea Virus major glycoprotein E2. Journal of general Virology 1999; 80: 3137-44

.Hellen C, Breyne S. A distinct group of Hepacivirus/Pestiviru_like Internal Ribosomal Entry Sites (IRES) in members of Diverse Picornavirus genera: Evidence for Modular Exchange of Functional Noncoding RNA elements by Recombination. Journal of Virology 2007; 81: 5850-5863.

Houe H, Lindberg A, Moennig V. Test strategies in Bovine Viral Diarrhea Virus control and eradication campaigns in Europe. J Vet Diagn Invest 2006; 18: 427-36.

Houe H. Epidemiological features and economical importance of Bovine Viral Diarrhea Virus. Vet Microbiology 1999; 64: 89-107.

Jaime J. Infección persistente con el virus DVB en hatos lecheros de la Sabana de Bogotá. Tesis de Maestría, Facultad de Medicina Veterinaria, Universidad Nacional de Colombia, Bogotá, 1996.

Jooss K, Chimule N. Immunity Adenovirus and Adenovirus associated virus for gene therapy. Gene therapy 2003; 10: 955-63.Kelling C. Evolution of bovine viral diarrhea virus vaccines. Vet Clin Food Anim 2004; 20: 115-129.

Kovács F, Magyar T, Rinehart C, Elbers K, Ohnesorge WC. The live attenuate bovine viral diarrhea virus components of a multi-valent vaccine confer protection against fetal infection. Vet Microbiol 2003; 96: 117-131

Kowalczyk D, Erti H. Immune responses to DNA vaccines. Cell Mole Life Sci 1999; 55: 751-770.Lectora W. Diarrea viral bovina: Actualización. Rev Vet 2003; 14: 1-17.

Leitner, W., Ying, H., Restifo, N. DNA and RNA-based vaccines: principles progress and prospects. Vaccine 2000; 18: 765-77.

Lian R, Babiuk L. Compatibiility of plasmid encoding bovine viral diarrhea virus type 1 and type 2 E2 in a single DNA vaccine formulation. Vaccine 2007; 25: 5994-6006.

Liang R, Hurk J, Babiuk L, Hurk F. Priming with DNA encoding E2 and boosting with E2 protein formulated with CpG oligodeoxinucleotid induces strong immune response and protection from BVDV in cattle. Journal of general Virology 2006; 87: 2971-82.

Lindberg A, Alenius S. Principles for eradication of bovine viral diarrhea virus (BVDV) infectious in cattle populations. Vet Microbiol 1999; 64: 197-222.

Lindberg A, Browlie J, Gunn G, Houe H, Moennig V. The control of bovine viral diarrhea virus in Europe: today and in the future. Rev sci tech off int Epiz 2006; 25:961-979.

Liu Q, Murwe Da. Molecular basis of the infl ammatory response to Adenovirus vectors. Gene therapy 2003; 10: 935-940.

Makoschey B, Becher P, Orlich M, Thiel HJ, Lutticken D. Bovine viral diarrhea virus with deletions in the 5 ́-nontranslated region: reduction of replication in calves and induction of protective immunity. Vaccine 2004; 22:3285-3294.

Makoschey B, Janssen MG, Vrijenhoek MP, Korsten JHM. An inactivated bovine virus diarrhoea virus (BVDV) type 1 vaccine affords clinical protection against BVDV type 2. Vaccine 2001; 19:3261-3268.

Mehdy S, Shen S, Talbot B, Massie B, Harpin S, Elazhary Y. Recombinant adenoviruses expressing the E2 protein of Bovine Viral Diarrhea virus induce humoral and cellular responses. Microbiology Letters 1999; 177: 159-165.

Mettenleiter T, Sobrino F, editors. Animal Viruses: Molecular Biology. Madrid: Caister Academic Press; 2008.Moennig V, Eicken K, Flebbe U, Frey HR, Grummer B. Implementation of two-step vaccination in the control of bovine viral diarrhea (BVD). Prev Vet Med 2005; 72:109-114.

Muphy F, Fauquet C, Bishop D, Ghabrial S, Jarvis A, editors. Virus taxonomy: Sixth Report of the International Commitee on Taxonomy of virus. Vienna and New YorK: Spinger-verlag; 1999.

Nobiron I, Thompson I, Browlie J, Collins M. DNA vaccination against Bovine Viral Diarrhea Virus induces humoral and cellular responses in cattle with evidence for protection against viral challenge. Vaccine 2003; 21: 2082-92.

Nobiron I, Thompson I, Brownlie J, Collins M. Co-administration of IL-2 enhances antigen-specifi c immune responses following vaccination with DNA encoding the glycoprotein E2 of bovine viral diarrhea virus. Vet microbiol 2000; 76:129-142.

Oirschot J, Brruschke C, Rijn P. Vaccination of cattle against Bovine Viral Diarrhea Virus. Vet Microbiol1999; 64: 169-83.

Parra J. Infl uencia de la infección por el virus de la diarrea viral bovina (DVB) y de la coinfección con el virus de leucosis bovina, leptospira y rinotraqueitis bovina infecciosa (IBR) sobre la producción en ganado de leche. Universidad Nacional de Colombia 1994. Paton D, Sharp G, Ibata G. Fetal cross-protection experiments between type 1 and type 2 BVDV in pregnant ewes. Vet Microbiol 1999; 64: 185-196.

Polo JM, Dubensky TW. Virus-based vectors for human vaccine applications. Research focus 2002; 7: 719-728.

Potgieter L, Bovine Respiratory Tract Disease caused by Bovine Viral Diarrhea virus. Vet Clin North Am 1997; 13:471-481.

Ramírez MC. Evaluación de cultivos celulares y SFB con PEI en el estudio del virus DVB. Trabajo de investigación. Facultad de Medicina veterinaria, Universidad Nacional de Colombia, Bogotá 1993.

Ridpath J. Practical signifi cance of heterogeneity among BVDV strains: Impact of biotype and genotype on U.S. Control program. Prev Vet Med 2005; 72: 17-30.

Ridpath J, Neill J, Peterhans E. Impact of variation in acute virulence of BVDV 1 strain on design of better vaccine effi cacy challenge models. Vaccine 2007; 25: 8058-66.

Ridpath J, Neill J, Vilcek S, Dubovi E, Carman S. Multiple outbreaks of severe acute BVDV in North America occurring between 1993 and 1995 linked to the same BVDV2 strain. Vet Microbiology 2006; 114: 196-204.

Rossmanith W, Vilcek S, Wenzl H, Rossmanith E, Loitsch A, et al. Improved antigen and nucleic acid detection in a Bovine Viral Diarrhea Virus eradication program. Vet microbial 2001; 81: 207-218.

Saliki J, Dubovi E. Laboratory diagnosis of bovine viral diarrhea virus infections. Vet Clin Food Anim 2004; 20: 69-83.

Sandvik T. Selection and use laboratory diagnostic assays in BVD control programmers. Prev Vet Medicine 2005; 72: 3-16.

Sandvik T. Progress of control and prevention programs for Bovine Viral Diarrhea Virus in Europe. Vet Clin Food Anim 2004; 20: 151-169.

Souza A. Haut L, Reyes A., Pinto A. Recombinant viruses as vaccines against viral diseases 2005. Brazilian Journal of Medical and Biological research 38: 509-22.

Stokstad M, Brownlie J, Collins M. Analysis of variation BVDV E2 sequence following transplacental infection in cattle. Vet Microbiol 2004; 102: 141-45.

Synge B, Clark A, Moar J, Nicolson T, Nettleton P, et al. Control of Bovine Viral Diarrhea Virus In Shetland. Vet Microbiol 1999: 64: 223-229.

Valle P, Skjerve E, Wayne S, Larsen R, Nyberg O. Ten years of BVDV control in Norway: A cost benefi ts analysis. Prev Vet Med 2005; 72: 189.

Vera V, Ramirez G, Villamil L, Jaime J. Biología molecular, epidemiología y control de IBR y BVDV. ed. Universidad Nacional de Colombia, Bogotá 2003.

Vilcek S, Durkovic B, Kolesarova M, Paton D. Genetic diversity of BVDV: Consequences for classifi cation and molecular epidemiology. Prev Vet Med 2005; 72: 31-35.

Walz P, Bell T, Wells J, Grooms D, Kaiser L, et al. Relationship between degree of viremia and disease manifestations in calves with experimentally induced bovine viral diarrhea virus infection. Am J Vet Res 2001; 62: 1095-1103.

Wang L, Whitbeck C, Lawrence W, Volgin D, Bello L. Expression of the genomic form of the BVDV E2 ORF in a Bovine Herpesvirus-1 Vector. Virus genes 2003; 27:83-91.

Young N, Thomas C, Thompson I, Collins M, Brownlie J. Immune responses to non-strcutural protein 3 (NS3) of BVDV in NS3 DNA vaccinated and naturally infected cattle. Prev Vet Med 2005; 72: 115-120.




How to Cite

Vargas, D. S., Jaime, J., & Vera, V. J. (2009). Perspectivas para el control del Virus de la Diarrea Viral Bovina (BVDV). Revista Colombiana De Ciencias Pecuarias, 22(4), 12.